Entera Bio ENTX Cash Flow Statement (2017-2026)

NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Entera Bio Quarterly Cash Flow Statement

Periods 37 quarters
Latest Sep 2026

Entera Bio reported cash from operations of -$7.40M and free cash flow of -$7.42M for the quarter ended Sep 2026, down 195.7% year over year. This cash flow statement covers 37 quarters of results from Sep 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.02M-2.15M-3.02M-2.36M-2.57M-2.66M-3.20M-3.02M-3.51M-7.31M-15.60M
Depreciation and DepletionDep. & Depletion
0.01M0.02M0.02M0.02M0.02M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.02M0.02M0.02M0.02M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based CompensationStock Comp.
0.37M0.96M0.70M0.11M0.48M0.52M0.47M0.38M0.32M0.46M0.60M0.93M0.57M0.60M0.51M0.93M0.71M0.67M0.62M1.82M
Deferred Taxes
-0.05M-0.03M-0.03M0.21M0.02M0.03M0.01M
Other non-cash itemsOther Non-Cash
0.02M-0.04M-0.03M0.00M0.00M0.00M0.00M-0.01M0.02M-0.01M-0.01M0.00M0.01M0.00M0.02M-0.03M0.04M0.01M2.77M7.53M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.07M0.03M0.02M0.01M0.01M-0.22M-0.03M0.06M0.08M-0.01M
Change in Account PayablesChange Payables
-0.16M0.03M-0.09M0.30M-0.40M0.13M0.09M0.32M-0.48M-0.02M0.00M0.12M-0.05M0.00M0.25M-0.17M0.23M-0.17M0.30M-0.17M
Change in Accrued ExpensesChange Accrued Exp.
1.10M-0.81M-0.58M-0.76M0.58M0.06M0.19M-0.15M-0.66M0.03M0.17M-0.31M0.31M0.89M0.03M-0.08M0.20M0.00M-0.02M0.62M
Change in Other Operating AssetsOther Assets Change
-0.21M1.10M-0.40M-0.32M-0.34M0.36M0.00M-0.24M-0.17M0.32M-0.09M-0.19M-0.03M0.33M-0.08M-0.03M0.01M0.09M-0.05M3.58M
Change in Other Operating LiabilitiesOther Liabilities Change
0.02M-0.02M
Other Working Capital ChangesOther WC Changes
0.22M-1.11M0.40M0.32M0.34M-0.36M0.00M0.24M0.17M-0.32M0.09M0.19M0.03M-0.33M0.08M0.03M-0.01M-0.09M0.05M-3.58M
Other Operating Activities (as filed)
0.02M0.04M0.03M0.00M0.00M0.06M0.07M0.05M0.04M0.07M1.33M
Cash from OperationsCash from Ops.
-2.51M-4.79M-2.83M-2.87M-2.01M-1.61M-1.56M-1.53M-2.62M-1.86M-1.34M-2.15M-1.47M-1.40M-1.63M-2.50M-1.83M-3.09M-3.46M-7.40M
Investing Activities
Capital ExpendituresCapex
0.01M0.02M0.02M0.00M0.00M0.01M0.00M0.01M0.00M0.01M0.03M0.04M0.03M0.00M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.02M-0.02M0.00M0.00M-0.01M0.00M-0.01M0.00M-0.01M-0.03M-0.04M-0.03M0.00M-0.02M
Other Investing Activities (as filed)Other investing (as filed)
0.06M0.01M-0.08M8.09M0.00M0.02M-0.34M7.88M-0.66M-0.59M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.02M-0.02M-0.06M0.00M-0.01M0.00M-0.01M0.00M-0.01M-0.03M-0.04M-0.03M0.00M-0.02M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.02M0.01M0.01M6.61M0.03M1.24M0.01M3.52M6.33M-0.15M0.07M0.53M0.13M-0.13M
Net Shares Issued and RepurchasedNet Shares Issued
0.02M0.01M0.01M6.61M0.03M1.24M0.01M3.52M6.33M-0.15M0.07M0.53M0.13M-0.13M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.02M0.01M0.01M6.61M0.03M1.24M0.01M3.52M6.33M-0.15M0.07M0.53M0.13M-0.13M
Other financing activities (as filed)
-0.02M-0.30M-0.19M-0.08M0.00M-0.17M-14.09M
Cash from Financing ActivitiesCash from Financing
0.02M0.01M0.01M6.03M0.03M1.22M0.01M3.22M13.34M-0.05M0.25M0.17M0.13M9.96M261.41M
Additional items
Exchange Rate EffectFX Effect
0.03M-0.07M0.00M0.02M-0.01M
Change in Cash
-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.56M-1.53M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.30M-1.72M-2.96M6.49M253.99M
Ending Cash Balance
24.96M20.15M17.32M14.39M12.38M10.76M9.20M7.68M11.09M9.25M9.13M6.99M8.74M20.67M18.95M16.69M14.97M12.02M18.53M272.51M
Free Cash FlowFCF
-2.52M-4.82M-2.85M-2.87M-2.01M-1.62M-1.56M-1.53M-2.62M-1.86M-1.34M-2.15M-1.47M-1.41M-1.66M-2.55M-1.86M-3.09M-3.47M-7.42M
Net Cash FlowNCF
-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.56M-1.53M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.30M-1.69M-2.96M6.49M253.99M
Interest Paid

Entera Bio Cash Flow Statement API

Pull Entera Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ENTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY